NARRATIVE REVIEW2026
Semaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities.
Vahora S, Shah V, Patel B. Pharmaceutical Research. 2026;43(9):2989-3010.
What they did. The authors reviewed what is known about how semaglutide is absorbed and handled by the body. They focused on why the tablet form is absorbed so poorly and on newer formulation technologies meant to improve it.
What they found. This is a narrative review, not a new study, so it has no sample size of its own. The authors report that only a very small fraction of swallowed semaglutide reaches the bloodstream, even under tightly controlled conditions. This is because the peptide is broken down in the gut and crosses the gut wall poorly. They also report that the absorption enhancer SNAC protects the peptide in the stomach and helps it get absorbed, and that experimental delivery methods are still early-stage.
Why it matters for testing. The review shows that semaglutide's behaviour depends heavily on formulation, and that tablets also contain excipients such as SNAC. A product's label alone does not show that it contains intact semaglutide in the right amount, so identity and content testing are needed for each product type.
SYSTEMATIC REVIEW AND META-ANALYSIS (COCHRANE)2025
Semaglutide for adults living with obesity.
Bracchiglione J, Meza N, Franco JV, et al. Cochrane Database of Systematic Reviews. 2025;10(10):CD015092.
What they did. This WHO-funded Cochrane team combined randomised controlled trials that compared semaglutide with placebo or other weight-management drugs in adults with obesity. Each trial followed participants for at least six months.
What they found. The review included 18 randomised trials with 27,949 participants. Compared with placebo over 6 to 17 months, semaglutide led to more weight reduction (high-certainty evidence). Stopping treatment because of side effects was also more common on semaglutide. The review found little or no difference in quality of life and low-certainty or uncertain evidence on major heart events and death over that period. The authors note that the manufacturer had a major role in 17 of the 18 trials, and they call for independent studies.
Why it matters for testing. Every trial in this review used manufacturer-supplied, quality-controlled semaglutide. None of its findings carry over to research-grade or compounded products, whose identity, strength and purity have to be checked independently.
MARKET SURVEILLANCE AND PRODUCT TEST-PURCHASE STUDY2024
Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.
Ashraf AR, Mackey TK, Vida RG, et al. Journal of Medical Internet Research. 2024;26:e65440.
What they did. The researchers looked at how semaglutide is sold online without a prescription. They then bought products from the highest-ranking illegal online pharmacies and tested them for packaging quality, sterility, endotoxin, and semaglutide content and purity by liquid chromatography-mass spectrometry.
What they found. Out of 1,080 search-result links, the researchers identified 59 unique illegal online pharmacy websites. They placed orders with 6 sellers: 3 vials arrived, and none of the 3 ordered brand-name pens ever arrived. All 3 vials were judged probably substandard or falsified. Each vial contained 28.6–38.7% more semaglutide than its label stated, while measured purity was only 7.7–14.4% against a label claim of 99%. No living microorganisms were found, but endotoxin was detected in every sample. The study tested only three vials, so it cannot show how common these problems are.
Why it matters for testing. This study directly measured the problems a lot test is designed to catch: content that does not match the label, purity far below the claimed value, and endotoxin contamination in vials that were otherwise sterile. It shows why a microbial screen alone is not enough and endotoxin needs its own test.
Know what is in your vial
See every Semaglutide lot we have tested, or send yours in.
Summaries are written by Vialidate Labs from the published articles, via PubMed. Read the original papers for full methods and results. Vialidate reports analytical results only; nothing on this page is medical advice or a recommendation to use any compound.